Insider Sale at Nektar: What Jonathan Zalevsky’s 10b5‑1 Move Means for Shareholders
Insightful insider sale: Nektar’s R&D chief sold 3,867 shares at $35.67, a routine liquidity move that signals leadership confidence in the company’s pipeline while keeping the share price steady.
4 minutes to read